Literature DB >> 31351756

Communicating THC levels and 'dose' to consumers: Implications for product labelling and packaging of cannabis products in regulated markets.

David Hammond1.   

Abstract

In a well-regulated drug market, consumers should be able to understand and titrate their dose with little difficulty. In the cannabis market, despite substantial increases in THC levels over time, users have had limited information on the strength of their products. In principle, cannabis legalization provides greater opportunity to communicate clear, accurate information to consumers through packaging and labelling standards. However, jurisdictions that have legalized cannabis have experienced an increase in adverse events from higher strength products, particularly from edibles and other concentrates. What little research exists suggests that current regulatory practices of labelling THC levels on packages may be ineffective due to consumer difficulties understanding numbers (e.g., mg vs. percentage), and the different ways THC levels are communicated across product categories. In particular, current labelling practices provide little guidance in terms of 'dose expression'-how THC 'dose' translates into consumption amounts for specific products. The current paper identifies five principles to guide cannabis labelling and packaging regulations, including considerations for numeric THC labelling, the use of standard servings or dose across different product forms, strategies to communicate 'dose expression', and 'dose-unit packaging'. Overall, there is a need for regulated cannabis markets to develop more effective packaging and labelling standards to allow consumers to effectively titrate their THC intake, with the goal of promoting lower-risk cannabis use.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cannabis; Policy; Substance use

Mesh:

Substances:

Year:  2019        PMID: 31351756     DOI: 10.1016/j.drugpo.2019.07.004

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  12 in total

1.  Sources of cannabis among young adults and associations with cannabis-related outcomes.

Authors:  Elizabeth J D'Amico; Anthony Rodriguez; Michael S Dunbar; Caislin L Firth; Joan S Tucker; Rachana Seelam; Eric R Pedersen; Jordan P Davis
Journal:  Int J Drug Policy       Date:  2020-10-07

2.  Health considerations of the legalization of cannabis edibles.

Authors:  Jasleen K Grewal; Lawrence C Loh
Journal:  CMAJ       Date:  2020-01-06       Impact factor: 8.262

3.  Novel Nicotine Concentration Labels Improve Adolescents' and Young Adults' Understanding of the Nicotine Strength of Electronic Nicotine Delivery System Products.

Authors:  Meghan E Morean; Olivia A Wackowski; Thomas Eissenberg; Cristine D Delnevo; Suchitra Krishnan-Sarin; Ralitza Gueorguieva
Journal:  Nicotine Tob Res       Date:  2022-06-15       Impact factor: 5.825

Review 4.  Cannabis and driving ability.

Authors:  Eric L Sevigny
Journal:  Curr Opin Psychol       Date:  2021-03-17

5.  Associations between self-reported cannabis use frequency, potency, and cannabis/health metrics.

Authors:  Christine M Steeger; Leah N Hitchcock; Angela D Bryan; Kent E Hutchison; Karl G Hill; L Cinnamon Bidwell
Journal:  Int J Drug Policy       Date:  2021-05-30

6.  Knowledge of Tetrahydrocannabinol and Cannabidiol Levels Among Cannabis Consumers in the United States and Canada.

Authors:  David Hammond; Samantha Goodman
Journal:  Cannabis Cannabinoid Res       Date:  2020-10-29

7.  Requirements for Cannabis Product Labeling by U.S. State.

Authors:  Daniel J Kruger; Natalie J Korach; Jessica S Kruger
Journal:  Cannabis Cannabinoid Res       Date:  2021-01-11

8.  A Model of Combined Exposure to Nicotine and Tetrahydrocannabinol via Electronic Cigarettes in Pregnant Rats.

Authors:  Kristen R Breit; Cristina G Rodriguez; Samirah Hussain; Karen J Thomas; Mikayla Zeigler; Ioanna Gerasimidis; Jennifer D Thomas
Journal:  Front Neurosci       Date:  2022-03-16       Impact factor: 4.677

Review 9.  Cannabis Legalization and Acute Harm From High Potency Cannabis Products: A Narrative Review and Recommendations for Public Health.

Authors:  Justin Matheson; Bernard Le Foll
Journal:  Front Psychiatry       Date:  2020-09-23       Impact factor: 4.157

10.  Controlled administration of cannabis to mitigate cannabis-attributable harm among recreational users: a quasi-experimental study in Germany.

Authors:  Jakob Manthey; Jens Kalke; Jürgen Rehm; Moritz Rosenkranz; Uwe Verthein
Journal:  F1000Res       Date:  2020-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.